Kim SO - Search Results

1

Antiviral therapies: focus on hepatitis B reverse transcriptase.

Michailidis E, Kirby KA, Hachiya A, Yoo W, Hong SP, Kim SO, Folk WR, Sarafianos SG. Michailidis E, et al. Among authors: kim so. Int J Biochem Cell Biol. 2012 Jul;44(7):1060-71. doi: 10.1016/j.biocel.2012.04.006. Epub 2012 Apr 16. Int J Biochem Cell Biol. 2012. PMID: 22531713 Free PMC article. Review.

2

Detection of hepatitis B virus YMDD variants using mass spectrometric analysis of oligonucleotide fragments.

Hong SP, Kim NK, Hwang SG, Chung HJ, Kim S, Han JH, Kim HT, Rim KS, Kang MS, Yoo W, Kim SO. Hong SP, et al. Among authors: kim s, kim ht, kim so, kim nk. J Hepatol. 2004 May;40(5):837-44. doi: 10.1016/j.jhep.2004.01.006. J Hepatol. 2004. PMID: 15094233

3

[Reappraisal of HBV genotypes and clinical significance in Koreans using MALDI-TOF mass spectrometry].

Lee JM, Ahn SH, Chang HY, Shin JE, Kim DY, Sim MK, Hong SP, Chung HJ, Kim SO, Han KH, Chon CY, Moon YM. Lee JM, et al. Among authors: kim dy, kim so. Korean J Hepatol. 2004 Dec;10(4):260-70. Korean J Hepatol. 2004. PMID: 15613801 Korean.

4

Population genotyping of hepatitis C virus by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis of short DNA fragments.

Kim YJ, Kim SO, Chung HJ, Jee MS, Kim BG, Kim KM, Yoon JH, Lee HS, Kim CY, Kim S, Yoo W, Hong SP. Kim YJ, et al. Among authors: kim km, kim bg, kim cy, kim s, kim so. Clin Chem. 2005 Jul;51(7):1123-31. doi: 10.1373/clinchem.2004.047506. Epub 2005 May 12. Clin Chem. 2005. PMID: 15890891

5

Evaluation of methods for monitoring drug resistance in chronic hepatitis B patients during lamivudine therapy based on mass spectrometry and reverse hybridization.

Kim HS, Han KH, Ahn SH, Kim EO, Chang HY, Moon MS, Chung HJ, Yoo W, Kim SO, Hong SP. Kim HS, et al. Among authors: kim eo, kim so. Antivir Ther. 2005;10(3):441-9. Antivir Ther. 2005. PMID: 15918335

6

[Association between CCR5 promoter polymorphisms and hepatitis B virus infection].

Chang HY, Ahn SH, Kim DY, Shin JS, Kim YS, Hong SP, Chung HJ, Kim SO, Yoo WD, Han KH. Chang HY, et al. Among authors: kim dy, kim ys, kim so. Korean J Hepatol. 2005 Jun;11(2):116-24. Korean J Hepatol. 2005. PMID: 15980670 Korean.

7

Predominance of hepatitis B virus YMDD mutants is prognostic of viral DNA breakthrough.

Lee CH, Kim SO, Byun KS, Moon MS, Kim EO, Yeon JE, Yoo W, Hong SP. Lee CH, et al. Among authors: kim eo, kim so. Gastroenterology. 2006 Apr;130(4):1144-52. doi: 10.1053/j.gastro.2006.01.005. Gastroenterology. 2006. PMID: 16618409

8

Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy.

Lee YS, Suh DJ, Lim YS, Jung SW, Kim KM, Lee HC, Chung YH, Lee YS, Yoo W, Kim SO. Lee YS, et al. Among authors: kim km, kim so. Hepatology. 2006 Jun;43(6):1385-91. doi: 10.1002/hep.21189. Hepatology. 2006. PMID: 16729316

9

The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B.

Paik YH, Han KH, Hong SP, Lee HW, Lee KS, Kim SO, Shin JE, Ahn SH, Chon CY, Moon YM. Paik YH, et al. Among authors: kim so. Antivir Ther. 2006;11(4):447-55. Antivir Ther. 2006. PMID: 16856618 Clinical Trial.

10

Levels of hepatitis B virus (HBV) replication during the nonreplicative phase: HBV quantification by real-time PCR in Korea.

Yim HJ, Byun KS, Chang YJ, Suh YS, Yeon JE, Lee CH, Kwon JA, Yoo W, Kim SO, Hong SP. Yim HJ, et al. Among authors: kim so. Dig Dis Sci. 2007 Sep;52(9):2403-9. doi: 10.1007/s10620-006-9140-2. Epub 2007 Apr 11. Dig Dis Sci. 2007. PMID: 17429737

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,691 results

Search Page

Filters